Amazon Acetaminophen Recall Affects 112,932 Bottles Nationwide
Amazon Acetaminophen Recall Affects More Than 112,000 Bottles Nationwide
A nationwide Amazon acetaminophen recall affects 112,932 bottles of Amazon Basic Care Extra Strength Acetaminophen, following consumer complaints about discolored tablets. Aurobindo Pharma USA Inc. initiated the voluntary recall September 18, 2026, involving 500-milligram caplets sold through Amazon. The recall has drawn renewed national attention this week, with reports published October 13 and 14.
The affected medication was distributed nationwide in 200-count, 500-count and 1,000-count bottles, including products purchased by Oklahoma consumers. The U.S. Food and Drug Administration lists the recall in its enforcement reporting system. No adverse health events have been reported in connection with the affected products, and the FDA had not assigned a final recall classification as of the latest available reporting.
Amazon Acetaminophen Recall Includes Seven Product Lots
The FDA's drug recall reporting system provides information about recalled medications, including affected products and manufacturing details.
The recall covers 14,640 bottles containing 200 caplets, identified by lot ACD125040A, with an expiration date of September 30, 2027.
Another 90,456 bottles containing 500 caplets are affected. Those lots include ACD124036A, ACD124030A, ACD124042A, ACD124048B and ACD125010A, with expiration dates ranging from September 2027 through February 2028.
The remaining 7,836 bottles contain 1,000 caplets, identified by lot ACD124048A, expiring November 30, 2027.
What Consumers Should Do With Recalled Medication
Consumers who purchased Amazon Basic Care Extra Strength Acetaminophen should compare their bottle's lot number with the recalled products.
Amazon has reportedly contacted affected customers and is providing refunds after confirmation that recalled medication has been discarded.
Customers can review notices through Amazon's Product Safety Alerts to determine whether their purchases are affected.
Consumers should discontinue use of medication from the recalled lots and consult a pharmacist or healthcare professional with questions about the product.
FDA Continues Monitoring Nationwide Medication Recall
The recall was initiated after complaints that some tablets appeared discolored. The FDA's classification process evaluates the potential health risks associated with recalled products.
The agency's recall classification guidance explains how recalls are evaluated and assigned risk categories.
Although no adverse health events have been reported, consumers should not assume that every bottle of Amazon-branded acetaminophen is affected.
Only the identified product lots are included in this recall. Consumers should verify their medication's identifying information before disposing of products or requesting refunds.
Comments